(Total Views: 158)
Posted On: 11/30/2022 11:23:59 AM
Post# of 40312

$LUDG to announce that the company is planning to file a form S-1 registration statement. The company has engaged the Newlin Law Firm to complete the S1 registration statement. Additional needed steps include completing a PCAOB (SEC Peer Reviewed) audit and retaining a professional firm to research and complete our business plan.
Thanks to Precision Genomics' success, a wholly owned subsidiary of Ludwig, in featuring Marvin S. Hausman, MD, at the LD Micro Conference, Los Angeles, CA last month, the company has attracted strong interest and has received terms from several investment banks and family offices. In addition, the company is confident it will complete a bridge financing round of $1 million (One million dollars), with $500k already raised in a family and friends' round. The company is targeting the IPO (S1) launch in Q1 of 2023.
Thanks to Precision Genomics' success, a wholly owned subsidiary of Ludwig, in featuring Marvin S. Hausman, MD, at the LD Micro Conference, Los Angeles, CA last month, the company has attracted strong interest and has received terms from several investment banks and family offices. In addition, the company is confident it will complete a bridge financing round of $1 million (One million dollars), with $500k already raised in a family and friends' round. The company is targeting the IPO (S1) launch in Q1 of 2023.


Scroll down for more posts ▼